However, because it causes weight loss as a side effect, some doctors prescribe it "off-label" for weight management
Aschner P, Sethi B, Gomez-Peralta F et al (2015) Insulin glargine compared with premixed insulin for management of insulin-nave type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study
The food stays in the stomach for longer periods of time
NHS Prescription Costs vs Private GLP-1 Treatment Understanding the cost difference between NHS and private GLP-1 treatment is essential for patients considering these medications
Ipamorelin leads the way in peptide science
Collectively, these observations support the view that inter-individual variability in GLP-1 RA efficacy may, at least in part, reflect differences in baseline gut barrier integrity and microbiome functional capacity, which may distinguish responders from non-responders